ACHE and Alzheimer disease: This drug is a reversible, highly selective, and long-acting AChEI, which primarily inhibits acetylcholinesterase activity in the brain with its specificity, thereby increasing the concentration of acetylcholine, overcoming problems such as memory decline triggered by choline deficiency, and further improving cognitive function in AD patients [17, 18].